MedTrace Logo

Narcotic-Free Percutaneous Nephrolithotomy

NCT05924165 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-03-26

Study results available
· View outcomes & findings →

Summary

This is a randomized control trial comparing oral ketorolac and opioid medication for the use of post-operative analgesia.

Conditions

  • Nephrolithiasis

Interventions

DRUG

5mg Oxycodone, Q6 PRN

Oxycodone is an opioid that is used to relieve moderate to severe pain.

DRUG

10mg Ketorolac, Q6 PRN

Ketorolac is an NSAID used to relieve moderately severe pain.

Sponsors & Collaborators

Principal Investigators

  • Mantu Gupta, MD · Icahn School of Medicine at Mount Sinai

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-19
Primary Completion
2025-01-07
Completion
2025-01-07
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05924165 on ClinicalTrials.gov